TREM2 and neoplasm: QRHXF enhanced antitumor immune responses in NSCLC via TREM2 and modulation of the PI3K/AKT/STAT6 signaling pathway, reducing chemotactic infiltration of M2 tumor-associated macrophages within the TME.